Correction to Paladugu et al. ijms

The original images used to generate the data for the original paper was not documented properly so the histology and western blot data were regenerated and documented properly in the corrected version. Although the major findings of the original manuscript, that liraglutide can reduce inflammation and beta amyloid deposition, the streptozotocin treatments only exacerbated neuropathology in the 5xFAD mice but failed to provide significant neuropathology in wild-type mice, as was reported in the original manuscript. Also, the data showing disruption of insulin signaling pathway in the original version was not corroborated by the recent data as can ascertained by the new results in the corrected version of the manuscript. All of the histological and western blot images, data, and statistical analyses for the corrected version are provided here.